Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Journal of clinical microbiology - 60(2022), 2 vom: 16. Feb., Seite e0247921 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Deerain, Joshua [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antigen tests |
|---|
| Anmerkungen: |
Date Completed 23.02.2022 Date Revised 04.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1128/jcm.02479-21 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334724414 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334724414 | ||
| 003 | DE-627 | ||
| 005 | 20231225224323.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/jcm.02479-21 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1115.xml |
| 035 | |a (DE-627)NLM334724414 | ||
| 035 | |a (NLM)34936477 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Deerain, Joshua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.02.2022 | ||
| 500 | |a Date Revised 04.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Omicron | |
| 650 | 4 | |a antigen tests | |
| 650 | 4 | |a diagnostics | |
| 650 | 4 | |a infectious disease | |
| 700 | 1 | |a Druce, Julian |e verfasserin |4 aut | |
| 700 | 1 | |a Tran, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Batty, Mitchell |e verfasserin |4 aut | |
| 700 | 1 | |a Yoga, Yano |e verfasserin |4 aut | |
| 700 | 1 | |a Fennell, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Dwyer, Dominic E |e verfasserin |4 aut | |
| 700 | 1 | |a Kok, Jen |e verfasserin |4 aut | |
| 700 | 1 | |a Williamson, Deborah A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical microbiology |d 1975 |g 60(2022), 2 vom: 16. Feb., Seite e0247921 |w (DE-627)NLM000005460 |x 1098-660X |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2022 |g number:2 |g day:16 |g month:02 |g pages:e0247921 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/jcm.02479-21 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2022 |e 2 |b 16 |c 02 |h e0247921 | ||